I understand your slip in confidence due to the last month. I agree GC is a young, still somewhat green, CEO. But he is surrounded by industry vets with a lot of experience and intelligence.

After last night's blog, I feel a bit better, but not quite up to where I felt a month ago. I have continued to buy on the dips though as I still believe long term we have a winner here.

I see all of the confusion/frustration/anger/bashing/pumping of LymPro over the last few weeks and when I step back, it is somewhat amusing. If the AMBS team and the scientific commnity (along with a partner) feels strongly about the test, than that is enough for me for right now. We only need LymPro to bridge the gap to MANF, but I do hope LymPro becomes a powerhouse in its own right down the road.

I try to keep a big picture mentality, but it can be tough with weeks like the last 5. I appreciate all the thoughts on this board and the input. It helps me work through some of the emotions.

Now YMB on the other hand is insane. Ihub is not too far behind. I prefer it here.